|
|
|
May 21, 2012 | Accelrys has bought a Cloud-based drug discovery and development platform from SCYNEXIS, completing the contract both companies entered into last year to use Accelrys' Cheminformatics Suite on the SCYNEXIS platform. Zacks Investment Research
|
|
|